57 related articles for article (PubMed ID: 12112157)
21. The relation of White Matter Hyperintensities to implicit learning in healthy older adults.
Aizenstein HJ; Nebes RD; Meltzer CC; Fukui MB; Williams RL; Saxton J; Houck PR; Carter CS; Reynolds CF; DeKosky ST
Int J Geriatr Psychiatry; 2002 Jul; 17(7):664-9. PubMed ID: 12112165
[TBL] [Abstract][Full Text] [Related]
22. White matter hyperintensity progression and late-life depression outcomes.
Taylor WD; Steffens DC; MacFall JR; McQuoid DR; Payne ME; Provenzale JM; Krishnan KR
Arch Gen Psychiatry; 2003 Nov; 60(11):1090-6. PubMed ID: 14609884
[TBL] [Abstract][Full Text] [Related]
23. Morphological substrate of face matching in healthy ageing and mild cognitive impairment: a combined MRI-fMRI study.
Teipel SJ; Bokde AL; Born C; Meindl T; Reiser M; Möller HJ; Hampel H
Brain; 2007 Jul; 130(Pt 7):1745-58. PubMed ID: 17566054
[TBL] [Abstract][Full Text] [Related]
24. Estrogen replacement therapy for menopausal women with a history of breast carcinoma: results of a 5-year, prospective study.
Vassilopoulou-Sellin R; Cohen DS; Hortobagyi GN; Klein MJ; McNeese M; Singletary SE; Smith TL; Theriault RL
Cancer; 2002 Nov; 95(9):1817-26. PubMed ID: 12404273
[TBL] [Abstract][Full Text] [Related]
25. White matter lesions on magnetic resonance imaging and their relationship with vascular risk factors in memory clinic attenders.
Lazarus R; Prettyman R; Cherryman G
Int J Geriatr Psychiatry; 2005 Mar; 20(3):274-9. PubMed ID: 15717341
[TBL] [Abstract][Full Text] [Related]
26. Focal atrophy and cerebrovascular disease increase dementia risk among cognitively normal older adults.
Rosano C; Aizenstein HJ; Wu M; Newman AB; Becker JT; Lopez OL; Kuller LH
J Neuroimaging; 2007 Apr; 17(2):148-55. PubMed ID: 17441836
[TBL] [Abstract][Full Text] [Related]
27. Brain flexibility and balance and gait performances mark morphological and metabolic abnormalities in the elderly.
Ben Salem D; Walker PM; Aho S; Tavernier B; Giroud M; Tzourio C; Ricolfi F; Brunotte F
J Clin Neurosci; 2008 Dec; 15(12):1360-5. PubMed ID: 18954988
[TBL] [Abstract][Full Text] [Related]
28. Subclinical brain magnetic resonance imaging abnormalities predict physical functional decline in high-functioning older adults.
Rosano C; Kuller LH; Chung H; Arnold AM; Longstreth WT; Newman AB
J Am Geriatr Soc; 2005 Apr; 53(4):649-54. PubMed ID: 15817012
[TBL] [Abstract][Full Text] [Related]
29. Association of white-matter lesions with brain atrophy markers: the three-city Dijon MRI study.
Godin O; Maillard P; Crivello F; Alpérovitch A; Mazoyer B; Tzourio C; Dufouil C
Cerebrovasc Dis; 2009; 28(2):177-84. PubMed ID: 19556771
[TBL] [Abstract][Full Text] [Related]
30. Estrogen replacement therapy and MRI-demonstrated cerebral infarcts, white matter changes, and brain atrophy in older women: the Cardiovascular Health Study.
Luoto R; Manolio T; Meilahn E; Bhadelia R; Furberg C; Cooper L; Kraut M
J Am Geriatr Soc; 2000 May; 48(5):467-72. PubMed ID: 10811537
[TBL] [Abstract][Full Text] [Related]
31. Preliminary evidence that long-term estrogen use reduces white matter loss in aging.
Ha DM; Xu J; Janowsky JS
Neurobiol Aging; 2007 Dec; 28(12):1936-40. PubMed ID: 17030475
[TBL] [Abstract][Full Text] [Related]
32. Effects of estrogen replacement therapy on human brain aging: an in vivo 1H MRS study.
Robertson DM; van Amelsvoort T; Daly E; Simmons A; Whitehead M; Morris RG; Murphy KC; Murphy DG
Neurology; 2001 Dec; 57(11):2114-7. PubMed ID: 11739837
[TBL] [Abstract][Full Text] [Related]
33. Hormone replacement therapy, brain volumes and white matter in postmenopausal women aged 60-64 years.
Low LF; Anstey KJ; Maller J; Kumar R; Wen W; Lux O; Salonikas C; Naidoo D; Sachdev P
Neuroreport; 2006 Jan; 17(1):101-4. PubMed ID: 16361959
[TBL] [Abstract][Full Text] [Related]
34. Estrogen replacement therapy, cognition, and cerebral changes by MRI in the cardiovascular health study.
Coker LH; Shumaker SA
J Am Geriatr Soc; 2000 May; 48(5):588-9. PubMed ID: 10811555
[No Abstract] [Full Text] [Related]
35. The estrogen debate: to be (old) or not to be (old).
Goltzman D
Can J Surg; 1995 Oct; 38(5):396-7. PubMed ID: 7553458
[No Abstract] [Full Text] [Related]
36. [Morphological basis for aging of the brain].
Kulczycki J
Neuropatol Pol; 1973; 11(5):191-8. PubMed ID: 4759155
[No Abstract] [Full Text] [Related]
37. [Morphological and neurochemical dysfunctions in normal cerebral aging].
Zarranz JJ
Rev Neurol; 1997 Jul; 25 Suppl 1():S9-13. PubMed ID: 9280676
[No Abstract] [Full Text] [Related]
38. Age and Sex-Related Effects on Single-Subject Gray Matter Networks in Healthy Participants.
Shigemoto Y; Sato N; Maikusa N; Sone D; Ota M; Kimura Y; Chiba E; Okita K; Yamao T; Nakaya M; Maki H; Arizono E; Matsuda H
J Pers Med; 2023 Feb; 13(3):. PubMed ID: 36983603
[TBL] [Abstract][Full Text] [Related]
39. Longitudinal assessment of global and regional rate of grey matter atrophy in 1,172 healthy older adults: modulation by sex and age.
Crivello F; Tzourio-Mazoyer N; Tzourio C; Mazoyer B
PLoS One; 2014; 9(12):e114478. PubMed ID: 25469789
[TBL] [Abstract][Full Text] [Related]
40. Neuroprotective effects of estrogen therapy for cognitive and neurobiological profiles of monkey models of menopause.
Voytko ML; Tinkler GP; Browne C; Tobin JR
Am J Primatol; 2009 Sep; 71(9):794-801. PubMed ID: 19475542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
